Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 8/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.56 |
| ▸ | GRPR | P30550 | 6/20 | 0.55 |
| ▸ | GHSR | Q92847 | 2/20 | 0.52 |
| ▸ | REN | P00797 | 1/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18857750 | 0.94 | IL23R (0.57) | IL23RKISS1RGRPRNR3C1 | |
| SCHEMBL18854337 | 0.92 | KISS1R (0.56) | IL23RKISS1RGRPRGHSRREN | |
| SCHEMBL18857406 | 0.92 | CXCR4 (0.58) | IL23RGRPR | |
| SCHEMBL18862442 | 0.88 | GHSR (0.56) | GHSRREN | |
| SCHEMBL18854331 | 0.88 | GHSR (0.56) | GRPRGHSRREN | |
| SCHEMBL18857723 | 0.87 | KISS1R (0.51) | IL23RKISS1RGRPRNR3C1 | |
| SCHEMBL18854323 | 0.87 | GHSR (0.59) | KISS1RGHSRREN | |
| SCHEMBL18854321 | 0.86 | GRPR (0.50) | IL23RKISS1RGRPR | |
| SCHEMBL18854272 | 0.85 | GRPR (0.49) | IL23RKISS1RGRPR | |
| SCHEMBL18854269 | 0.84 | GHSR (0.60) | GRPRGHSRREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017083368-A9 | TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 | PFIZER INC. (US) | 2018-04-12 | — | — | WO | disclosed |
| WO-2017083368-A1 | TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 | PFIZER INC. (US) | 2017-05-18 | — | — | WO | disclosed |
| US-20170137801-A1 | TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-05-18 | — | — | US | disclosed |